Cyclin-dependent kinase 11 (CDK11) is crucial in the growth of liposarcoma cells
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference43 articles.
1. A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas;Matushansky;The American Journal of Pathology,2008
2. World health organization classification of bone and soft tissue tumors: modifications and implications for radiologists;Murphey;Seminars in Musculoskeletal Radiology,2007
3. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas
4. Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study
5. Diagnosis, management, and outcome of patients with dedifferentiated liposarcoma systemic metastasis;Ghadimi;Annals of Surgical Oncology,2011
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploration of Potential Cyclin-dependent Kinases and their Inhibitors to Combat Abnormal Signalling and Cancer;Current Signal Transduction Therapy;2024-07
2. Targeting pre-mRNA splicing in cancers: roles, inhibitors, and therapeutic opportunities;Frontiers in Oncology;2023-06-05
3. Synthesis of tricyclic and tetracyclic benzo[6,7]cycloheptane derivatives linked morpholine moiety as CDK2 inhibitors;Drug Development Research;2023-05-12
4. Therapeutic Implications of CDKs in Breast Cancer;Therapeutic potential of Cell Cycle Kinases in Breast Cancer;2023
5. Mitochondrial ribosomal small subunit (MRPS) MRPS23 protein–protein interaction reveals phosphorylation by CDK11-p58 affecting cell proliferation and knockdown of MRPS23 sensitizes breast cancer cells to CDK1 inhibitors;Molecular Biology Reports;2022-08-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3